Ondansetron for stomach nerve and motion problems in diabetes
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests whether ondansetron can improve stomach “sensorimotor” problems—how the gut senses food and moves it—especially in people with diabetes and troubling indigestion. It may help reduce symptoms like early fullness, nausea, and discomfort after eating.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be age 18–75 and able to sign consent before joining
- You have symptoms of indigestion such as early fullness, nausea, vomiting, regurgitation, or post-meal discomfort
- If you have diabetes: it must be type 1 or type 2 for at least 3 years, and for type 2 the symptoms should have started or worsened after diabetes was diagnosed
- You must be able to communicate with the study team and eat the study meals as instructed
- You should NOT be pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 trial tests whether ondansetron (a medicine used to reduce nausea and vomiting) works better than a placebo, along with usual care, for adults with acute gastroenteritis. It also checks how safe ondansetron is in this setting, especially for the heart rhythm and other side effects.
This study looks at how diabetes affects stomach function by measuring stomach activity with special tests. It may help doctors better understand and treat stomach problems in people with diabetes.
This trial tests whether a nausea medicine called ondansetron helps people feel better and lets doctors work more efficiently during a camera test (endoscopy) for upper GI bleeding. If you need an emergency endoscopy for bleeding, ondansetron may reduce discomfort.
This trial tests whether ondansetron, a medicine that helps control nausea and vomiting, can reduce the risk of pancreatitis (inflammation of the pancreas) after an ERCP procedure. If you are scheduled for an ERCP and do not have certain health issues, you may be able to join.
This trial tests if a combination of a nausea medicine (ondansetron) and a numbing spray (dyclonine) can make having a stomach scope test more comfortable for people who are awake during it.
This trial tests two medications, acotiamide and itopride, to see which one better relieves symptoms like fullness and bloating after eating. It is for people diagnosed with postprandial distress syndrome (a type of functional dyspepsia).
Hear when a new Indigestion trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.